药品研发者、基础研究者和病人之间共享信息的竞争前（pre-competitive）公私合作已成为将科学发现转化为潜在的有意义的临床效果的越来越普遍的方式。
And public-private partnerships between drug developers, basic researchers, and patient groups that share information pre-competitively (that is, with no or limited patent filings) are an increasingly popular way to translate scientific findings into potentially meaningful clinical benefits.